HCWB is trading 15% down at $0.95 after its Board approved a 1-for-6 reverse stock split aimed at maintaining compliance with Nasdaq’s $1.00 minimum bid price rule.

  • The reverse split is scheduled to become effective on June 30, 2026.
  • Traders often react negatively to reverse split announcements in the micro-cap biotech sector, which can amplify volatility and selling pressure.